Pu Li

2.2k total citations
52 papers, 1.7k citations indexed

About

Pu Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Pu Li has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 28 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Pu Li's work include MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (12 papers) and Circular RNAs in diseases (9 papers). Pu Li is often cited by papers focused on MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (12 papers) and Circular RNAs in diseases (9 papers). Pu Li collaborates with scholars based in China, United States and Qatar. Pu Li's co-authors include Xuehua Chen, Zhenggang Zhu, Bingya Liu, Liping Su, Qu Cai, Hua Tang, Beiqin Yu, Changjun Yin, Qiaoming Zhi and Chao Qin and has published in prestigious journals such as PLoS ONE, Hepatology and Cancer Research.

In The Last Decade

Pu Li

52 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pu Li China 24 1.3k 997 330 173 153 52 1.7k
Long Huang China 25 1.2k 0.9× 902 0.9× 296 0.9× 150 0.9× 185 1.2× 72 1.7k
Yiji Liao China 19 1.2k 1.0× 699 0.7× 285 0.9× 100 0.6× 122 0.8× 28 1.6k
Dandan Wang China 29 1.2k 1.0× 1.1k 1.1× 190 0.6× 120 0.7× 114 0.7× 62 1.8k
Pai‐Sheng Chen Taiwan 16 1.4k 1.1× 783 0.8× 244 0.7× 126 0.7× 119 0.8× 37 1.8k
Xi Liu China 22 1.2k 0.9× 866 0.9× 272 0.8× 138 0.8× 178 1.2× 67 1.8k
Yaguang Weng China 25 924 0.7× 549 0.6× 276 0.8× 166 1.0× 101 0.7× 53 1.4k
Amy Clem United States 18 1.3k 1.0× 1.0k 1.0× 412 1.2× 298 1.7× 84 0.5× 23 1.9k
Suhail Ahmed Kabeer Rasheed Singapore 13 1.7k 1.3× 1.4k 1.5× 243 0.7× 133 0.8× 97 0.6× 16 2.1k

Countries citing papers authored by Pu Li

Since Specialization
Citations

This map shows the geographic impact of Pu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pu Li more than expected).

Fields of papers citing papers by Pu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pu Li. The network helps show where Pu Li may publish in the future.

Co-authorship network of co-authors of Pu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Pu Li. A scholar is included among the top collaborators of Pu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pu Li. Pu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lili, Hui Yang, Pu Li, et al.. (2025). Genomic Profiling and Virulence Characterization of Cronobacter sakazakii Strains Isolated from Powdered Spices and Instant Cereals in Nanning, China. Foodborne Pathogens and Disease. fpd20240180–fpd20240180. 1 indexed citations
2.
Niu, Chuanxin M., Wu Lv, Xinyuan Zhu, et al.. (2024). Intestinal Translocation of Live Porphyromonas gingivalis Drives Insulin Resistance. Journal of Dental Research. 103(2). 197–207. 10 indexed citations
3.
Chen, Xuehua, et al.. (2023). Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases. Journal of Translational Medicine. 21(1). 203–203. 23 indexed citations
4.
Zhang, Di, Fangfang Yu, Huanhuan Li, et al.. (2022). AgNPs reduce reproductive capability of female mouse for their toxic effects on mouse early embryo development. Human & Experimental Toxicology. 41. 3520098475–3520098475. 3 indexed citations
5.
Gao, Yujing, Rui Ma, Jinpeng Wang, et al.. (2022). MIIP functions as a novel ligand for ITGB3 to inhibit angiogenesis and tumorigenesis of triple-negative breast cancer. Cell Death and Disease. 13(9). 810–810. 7 indexed citations
6.
Wang, Xinqiong, et al.. (2021). ERp29 forms a feedback regulation loop with microRNA-135a-5p and promotes progression of colorectal cancer. Cell Death and Disease. 12(11). 965–965. 8 indexed citations
7.
Gao, Yujing, Xuehua Chen, Rongrong Xu, et al.. (2018). Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial–mesenchymal transition. Journal of Translational Medicine. 16(1). 38–38. 19 indexed citations
8.
Sheng, Hong, et al.. (2016). Omega-3 Polyunsaturated Fatty Acids Enhance Cisplatin Efficacy in Gastric Cancer Cells by Inducing Apoptosis via ADORA1. Anti-Cancer Agents in Medicinal Chemistry. 16(9). 1085–1092. 17 indexed citations
9.
Shan, Guoping, et al.. (2016). Numb Gene Enhances Radiation Sensitivity of Nonsmall Cell Lung Cancer Stem Cells. Cancer Biotherapy and Radiopharmaceuticals. 31(5). 180–188. 5 indexed citations
10.
Liu, Yiyang, Jian Qian, Meiling Bao, et al.. (2015). miR-134 Functions as a Tumor Suppressor in Cell Proliferation and Epithelial-to-Mesenchymal Transition by Targeting KRAS in Renal Cell Carcinoma Cells. DNA and Cell Biology. 34(6). 429–436. 58 indexed citations
11.
Han, Ye, Xiaofeng Xue, Wei Li, et al.. (2015). Epidermal growth factor-like domain 7 promotes cell invasion and angiogenesis in pancreatic carcinoma. Biomedicine & Pharmacotherapy. 77. 167–175. 24 indexed citations
12.
Xue, Xiaofeng, Fei Liu, Ye Han, et al.. (2014). Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer. Biochemical and Biophysical Research Communications. 450(2). 1058–1062. 31 indexed citations
13.
Han, Ye, Xiaofeng Xue, Min Jiang, et al.. (2014). LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 39(2). 267–273. 34 indexed citations
14.
Wang, Junqing, Liping Su, Xuehua Chen, et al.. (2014). MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomedicine & Pharmacotherapy. 68(5). 557–564. 141 indexed citations
15.
Zhang, Jian, et al.. (2014). NF-κB-modulated miR-130a targets TNF-α in cervical cancer cells. Journal of Translational Medicine. 12(1). 155–155. 63 indexed citations
16.
Wu, Jing, Chaoming Mao, Jianmin Ren, et al.. (2013). A Lectin-EGF antibody promotes regulatory T cells and attenuates nephrotoxic nephritis via DC-SIGN on dendritic cells. Journal of Translational Medicine. 11(1). 103–103. 8 indexed citations
17.
Li, Pu, Xuehua Chen, Liping Su, et al.. (2013). Epigenetic Silencing of miR-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IP. PLoS ONE. 8(6). e66782–e66782. 63 indexed citations
18.
Li, Pu, Ying Lin, Yu Zhang, Zhenggang Zhu, & Keke Huo. (2013). SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinoma. Journal of Translational Medicine. 11(1). 52–52. 22 indexed citations
19.
Wang, Meilin, Haiyan Chu, Pu Li, et al.. (2012). Genetic Variants in miRNAs Predict Bladder Cancer Risk and Recurrence. Cancer Research. 72(23). 6173–6182. 73 indexed citations
20.
Shi, Danni, Pu Li, Lan Ma, et al.. (2012). A Genetic Variant in pre-miR-27a Is Associated with a Reduced Renal Cell Cancer Risk in a Chinese Population. PLoS ONE. 7(10). e46566–e46566. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026